CSF levels of dopamine and serotonin, but not norepinephrine, metabolites are influenced by the ketogenic diet in children with epilepsy

Epilepsy Research

Volumn 99, Issue 1-2, 2012, Pages 132-138

  Dahlin, Maria ^a   Månsson, Jan Eric ^b   Åmark, Per ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cerebrospinal fluid; Children; Dopamine; Ketogenic diet; Norepinephrine; Serotonin

Indexed keywords

4 HYDROXY 3 METHOXYPHENYLETHYLENE GLYCOL; 5 HYDROXYINDOLEACETIC ACID; CLOBAZAM; CLONAZEPAM; HOMOVANILLIC ACID; LAMOTRIGINE; LORAZEPAM; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PRIMIDONE; TOPIRAMATE; VALPROIC ACID;

ABSENCE; ADOLESCENT; ARTICLE; ATONIC SEIZURE; CEREBROSPINAL FLUID LEVEL; CHILD; CLINICAL ARTICLE; COMPLEX PARTIAL SEIZURE; DOPAMINE METABOLISM; EPILEPSY; FEMALE; FOCAL EPILEPSY; GENERALIZED EPILEPSY; HUMAN; INFANTILE SPASM; KETOGENIC DIET; LUMBAR PUNCTURE; MALE; METABOLITE; MYOCLONUS SEIZURE; NORADRENALIN RELEASE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SEROTONIN METABOLISM; SIMPLE PARTIAL SEIZURE; THERAPY EFFECT; TONIC CLONIC SEIZURE; TONIC SEIZURE; TREATMENT RESPONSE;

ADOLESCENT; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; DOPAMINE; EPILEPSY; FEMALE; HUMANS; INFANT; KETOGENIC DIET; MALE; NOREPINEPHRINE; SEROTONIN;

EID: 84857918294     PISSN: 09201211     EISSN: 18726844     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2011.11.003     Document Type: Article

References (20)

1. Al-Tajir G., Starr M.S. D-2 agonists protect rodents against pilocarpine-induced convulsions by stimulating D-2 receptors in the striatum, but not in the substantia nigra. Pharmacol. Biochem. Behav. 1991, 39:109-113.
2. Baf M.H., Subhash M.N., Lakshmana K.M., Rao B.S. Sodium valproate induced alterations in monoamine levels in different regions of the rat brain. Neurochem. Int. 1994, 24:67-72.
3. Bagdy G., Kecskemeti V., Riba P., Jakus R. Serotonin and epilepsy. J. Neurochem. 2007, 100(4):857-873.
4. Berg A.T., Berkovic S.F., Brodie M.J., Buchhalter J., Cross J.H., van Embe Boas W., Engel J., French J., Glauser T.A., Mathern G.W., Moshé S.L., Nordli D., Plouin P., Scheffer I. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005-2009. Epilepsia 2010, 4:676-685.
5. Blennow K., Wallin A., Gottfries C.G., Månsson J.-E., Svennerholm L. Concentration gradients for monoamine metabolites in lumbar cerebrospinal fluid. J. Neural Transm. 1993, 5:5-15.
6. Bozzi Y., Vallone D., Borrelli E. Neuroprotective role of dopamine against hippocampal cell death. J. Neurosci. 2000, 20:8643-8649.
7. Dahlin M., Ungerstedt U., Elwing Å., Åmark P. The ketogenic diet influences the levels of excitatory and inhibitory amino acids in the CSF in children with refractory epilepsy. Epilepsy Res. 2005, 64:115-125.
8. Freeman J.M., Kossoff E.H., Hartman A.L. The ketogenic diet: one decade later. Pediatrics 2007, 119(3):535-543.
9. Hartman A.L., Gasior M., Vining E.P., Rogawski M.A. The neuropharmacology of the ketogenic diet. Pediatr. Neurol. 2007, 36(5):281-292.
10. Hill K.K., West S.A., Ekhator N.N., Bruce A.B., Wortman M.D., Baker D.G., Geracioti T.D. The effect of lumbar puncture stress on dopamine and serotonin metabolites in human cerebrospinal fluid. Neurosci. Lett. 1999, 276(1):25-28.
11. Hyland K. Clinical utility of monoamine neurotransmitter metabolite analysis in cerebrospinal fluid. Clin. Chem. 2008, 54(April (4)):633-641.
12. 1A receptors activate the generation of spike-wave discharges in a genetic rat model of absence epilepsy. Exp. Neurol. 2003, 182:964-972.
13. Meshkibaf M.H., Subhash M.N., Lakshmana K.M., Rao B.S. Effect of chronic administration of phenytoin on regional monoamine levels in rat brain. Neurochem. Res. 1995, 20(7):773-778.
14. Scheinin M. Monoamine metabolites in human cerebrospinal fluid: indicators of neuronal activity?. Med. Biol. 1985, 63:1-17.
15. Swink T.D., Vining E.P.G., Freeman J.M. The ketogenic diet. Advances in Pediatrics 1997, vol. 44. Year Book, Mosby, pp. 297-329.
16. Szot P., Weinshenker D., Rho J.M., Storey T.W., Schwartzkroin P.A. Norepinephrine is required for the anticonvulsant effect of the ketogenic diet. Dev. Brain Res. 2001, 129:211-214.
17. Wada Y., Shiraishi J., Nakamura M., Koshino Y. Role of serotonin receptor subtypes in the development of amygdaloid kindling in rats. Brain Res. 1997, 747:338-342.
18. Weinshenker D. The contribution of norepinephrine and orexigenic neuropeptides to the anticonvulsant effect of the ketogenic diet. Epilepsia 2008, 49(Suppl. 8):104-107.
19. Weinshenker D., Szot P. The role of catecholamines in seizure susceptibility: new results using genetically engineered mice. Pharmacol. Ther. 2002, 94(3):213-233.
20. Yudkoff M., Daikhin Y., Nissim I., Lazarow A., Nissim I. Brain amino acid metabolism and ketosis. J. Neurosci. Res. 2001, 66:272-281.